$211 Million is the total value of Nan Fung Group Holdings Ltd's 45 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 50.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ILMN | ILLUMINA INC | $45,299,000 | -8.2% | 129,647 | 0.0% | 21.48% | +47.2% | |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | $37,398,000 | +14.1% | 768,708 | 0.0% | 17.74% | +82.9% | |
| KRTX | KARUNA THERAPEUTICS INC | $29,772,000 | -3.2% | 234,811 | 0.0% | 14.12% | +55.1% | |
| EAR | EARGO INC | $15,271,000 | +3.7% | 2,886,724 | 0.0% | 7.24% | +66.3% | |
| SOMALOGIC INC | $13,606,000 | -31.1% | 1,696,558 | 0.0% | 6.45% | +10.4% | ||
| EXSCIENTIA PLCads | $11,091,000 | -27.1% | 770,200 | 0.0% | 5.26% | +16.8% | ||
| SGEN | Buy | SEAGEN INC | $6,784,000 | -3.2% | 47,096 | +3.9% | 3.22% | +55.1% |
| RANI THERAPEUTICS HLDGS INC | $6,663,000 | -17.4% | 493,584 | 0.0% | 3.16% | +32.3% | ||
| XENE | XENON PHARMACEUTICALS INC | $6,049,000 | -2.2% | 197,880 | 0.0% | 2.87% | +56.9% | |
| VIR | VIR BIOTECHNOLOGY INC | $5,416,000 | -38.6% | 210,563 | 0.0% | 2.57% | -1.5% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $3,197,000 | -44.1% | 1,166,952 | 0.0% | 1.52% | -10.4% | |
| BEAM | BEAM THERAPEUTICS INC | $3,146,000 | -28.1% | 54,903 | 0.0% | 1.49% | +15.3% | |
| INCY | Sell | INCYTE CORP | $2,731,000 | +7.8% | 34,391 | -0.3% | 1.30% | +72.9% |
| BGNE | Buy | BEIGENE LTDsponsored adr | $2,267,000 | -25.3% | 12,022 | +7.3% | 1.08% | +19.7% |
| OTIC | Buy | OTONOMY INC | $2,043,000 | +15.4% | 851,080 | +0.0% | 0.97% | +84.9% |
| SRRA | SIERRA ONCOLOGY INC | $1,698,000 | +47.4% | 52,979 | 0.0% | 0.80% | +136.1% | |
| New | ENTRADA THERAPEUTICS INC | $1,630,000 | – | 173,582 | +100.0% | 0.77% | – | |
| GRTX | GALERA THERAPEUTICS INC | $1,459,000 | -48.2% | 613,223 | 0.0% | 0.69% | -16.9% | |
| EXEL | EXELIXIS INC | $1,455,000 | +23.9% | 64,200 | 0.0% | 0.69% | +98.8% | |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $1,318,000 | -62.5% | 144,840 | -15.7% | 0.62% | -39.9% |
| REPL | New | REPLIMUNE GROUP INC | $1,265,000 | – | 74,479 | +100.0% | 0.60% | – |
| NVTA | Sell | INVITAE CORP | $1,243,000 | -48.4% | 156,004 | -1.2% | 0.59% | -17.4% |
| EXAS | EXACT SCIENCES CORP | $1,221,000 | -10.2% | 17,464 | 0.0% | 0.58% | +44.0% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $1,160,000 | +11.4% | 78,720 | 0.0% | 0.55% | +78.6% | |
| CCXI | New | CHEMOCENTRYX INC | $898,000 | – | 35,830 | +100.0% | 0.43% | – |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $726,000 | -11.2% | 29,984 | -14.4% | 0.34% | +42.1% |
| ALXO | ALX ONCOLOGY HLDGS INC | $709,000 | -21.4% | 41,950 | 0.0% | 0.34% | +25.8% | |
| New | 2SEVENTY BIO INC | $687,000 | – | 40,273 | +100.0% | 0.33% | – | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $590,000 | -0.7% | 370,950 | 0.0% | 0.28% | +59.1% | |
| STSA | SATSUMA PHARMACEUTICALS INC | $543,000 | -15.6% | 142,900 | 0.0% | 0.26% | +35.8% | |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $489,000 | -71.2% | 4,168 | -66.9% | 0.23% | -53.8% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $471,000 | -28.5% | 6,115 | -18.0% | 0.22% | +14.4% |
| AFMD | New | AFFIMED N V | $355,000 | – | 81,172 | +100.0% | 0.17% | – |
| ARGX | Sell | ARGENX SEsponsored adr | $350,000 | -11.6% | 1,110 | -1.8% | 0.17% | +41.9% |
| RUBY | RUBIUS THERAPEUTICS INC | $313,000 | -43.1% | 56,768 | 0.0% | 0.15% | -9.2% | |
| SRPT | New | SAREPTA THERAPEUTICS INC | $306,000 | – | 3,917 | +100.0% | 0.14% | – |
| RETA | REATA PHARMACEUTICALS INCcl a | $271,000 | +24.3% | 8,265 | 0.0% | 0.13% | +98.5% | |
| FGEN | New | FIBROGEN INC | $177,000 | – | 14,756 | +100.0% | 0.08% | – |
| SYBX | SYNLOGIC INC | $165,000 | -0.6% | 68,634 | 0.0% | 0.08% | +59.2% | |
| KOD | Buy | KODIAK SCIENCES INC | $151,000 | -86.7% | 19,622 | +46.0% | 0.07% | -78.6% |
| ABCL | Sell | ABCELLERA BIOLOGICS INC | $122,000 | -35.1% | 12,521 | -5.0% | 0.06% | +3.6% |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $114,000 | -40.9% | 11,445 | 0.0% | 0.05% | -5.3% | |
| DYN | DYNE THERAPEUTICS INC | $112,000 | -18.8% | 11,629 | 0.0% | 0.05% | +29.3% | |
| CERS | New | CERUS CORP | $78,000 | – | 14,172 | +100.0% | 0.04% | – |
| TCRR | New | TCR2 THERAPEUTICS INC | $53,000 | – | 19,335 | +100.0% | 0.02% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -27,925 | -100.0% | -0.03% | – |
| VINC | Exit | VINCERX PHARMA INC | $0 | – | -11,050 | -100.0% | -0.03% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -11,650 | -100.0% | -0.05% | – |
| LIFE | Exit | ATYR PHARMA INC | $0 | – | -23,500 | -100.0% | -0.05% | – |
| AMYT | Exit | AMRYT PHARMA PLCsponsored ads | $0 | – | -19,150 | -100.0% | -0.06% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -15,545 | -100.0% | -0.06% | – |
| Exit | TSCAN THERAPEUTICS INC | $0 | – | -48,600 | -100.0% | -0.06% | – | |
| CNTA | Exit | CENTESSA PHARMACEUTICALS PLCsponsored ads | $0 | – | -22,200 | -100.0% | -0.07% | – |
| PRLD | Exit | PRELUDE THERAPEUTICS INC | $0 | – | -20,350 | -100.0% | -0.08% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -1,810 | -100.0% | -0.08% | – |
| Exit | TANGO THERAPEUTICS INC | $0 | – | -25,500 | -100.0% | -0.08% | – | |
| KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -4,960 | -100.0% | -0.09% | – |
| Exit | SURROZEN INC | $0 | – | -65,070 | -100.0% | -0.12% | – | |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -9,340 | -100.0% | -0.13% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -19,700 | -100.0% | -0.15% | – | |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -78,350 | -100.0% | -0.23% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -48,500 | -100.0% | -0.44% | – |
| NFHWS | Exit | NEW FRONTIER HEALTH CORP*w exp 11/30/202 | $0 | – | -1,580,000 | -100.0% | -1.26% | – |
| NFH | Exit | NEW FRONTIER HEALTH CORP | $0 | – | -8,350,000 | -100.0% | -28.31% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KARUNA THERAPEUTICS INC | 10 | Q3 2023 | 34.7% |
| HARMONY BIOSCIENCES HLDGS IN | 10 | Q3 2023 | 21.3% |
| XENON PHARMACEUTICALS INC | 10 | Q3 2023 | 3.1% |
| BOLT BIOTHERAPEUTICS INC | 10 | Q3 2023 | 5.6% |
| GALERA THERAPEUTICS INC | 10 | Q3 2023 | 1.9% |
| KALVISTA PHARMACEUTICALS INC | 10 | Q3 2023 | 1.8% |
| EXELIXIS INC | 10 | Q3 2023 | 1.1% |
| DBV TECHNOLOGIES S A | 10 | Q3 2023 | 0.6% |
| ALX ONCOLOGY HLDGS INC | 10 | Q3 2023 | 1.0% |
| ILLUMINA INC | 9 | Q3 2023 | 21.5% |
View Nan Fung Group Holdings Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eargo, Inc. | December 16, 2022 | 2,958,099 | 0.7% |
| Stealth BioTherapeutics Corp | January 09, 2020 | 20,240,817 | 4.8% |
| New Frontier Health Corp | January 02, 2020 | 9,650,000 | 7.3% |
View Nan Fung Group Holdings Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-16 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View Nan Fung Group Holdings Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.